Bioretec
0.71 EUR
+1.43 %
1,696 following
BRETEC
First North Finland
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Investor consensus
Valuation
Income statement
Quarterly estimates
Valuation
EV/S
Median 2021-2024
Dividend yield
Median 2021-2024
P/B
Median 2021-2024
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price (EUR) | 2.70 | 1.40 | 2.18 | 2.40 | 0.71 | 0.71 | 0.71 | 0.71 | |||
| Shares | 105.1 | 144.9 | 150.4 | 14.1 | 14.1 | 19.1 | 23.3 | 30.7 | 40.7 | 40.7 | 40.7 |
| Market cap | 38.1 | 19.8 | 41.7 | 56.0 | 21.8 | 28.9 | 28.9 | 28.9 | |||
| Enterprise value | 33.5 | 20.1 | 37.2 | 51.2 | 17.4 | 24.3 | 30.8 | 30.1 | |||
| EV/S | - | - | - | 16.7 | 6.8 | 9.5 | 11.3 | 4.6 | 4.8 | 3.9 | 2.7 |
| EV/EBITDA | - | - | - | neg. | neg. | neg. | neg. | neg. | neg. | neg. | 82.2 |
| EV/EBIT (adj.) | - | - | - | neg. | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| EV/EBIT | - | - | - | neg. | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/E (adj.) | - | - | - | neg. | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/E | - | - | - | neg. | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | - | - | - | 8.8 | 10.3 | 5.1 | 5.8 | 2.3 | 3.0 | 7.7 | 8.5 |
| P/S | - | - | - | 19.0 | 6.7 | 10.7 | 12.3 | 5.8 | 5.8 | 3.7 | 2.6 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | |||
| Equity ratio | 1.4 % | -77.2 % | 35.0 % | 50.3 % | 55.0 % | 77.2 % | 84.8 % | 83.4 % | 93.3 % | 62.0 % | 64.9 % |
| Gearing ratio | 2,641.2 % | -162.2 % | -16.2 % | -107.1 % | 17.9 % | -54.5 % | -49.5 % | -46.7 % | -47.1 % | 50.8 % | 34.6 % |